Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation

Human Molecular Genetics
Janet E DaviesDavid C Rubinsztein

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, progressive disease caused by the abnormal expansion of a polyalanine tract-encoding (GCG)(n) trinucleotide repeat in the poly-(A) binding protein nuclear 1 (PABPN1) gene. OPMD is generally inherited as an autosomal dominant disorder and the polyalanine expansion mutation is thought to confer a toxic gain-of-function on mutant PABPN1 which forms aggregates within skeletal myocyte nuclei. Here we describe a novel beneficial function of wild-type PABPN1. Wild-type PABPN1 over-expression can reduce mutant PABPN1 toxicity in both cell and mouse models of OPMD. In addition, wild-type PABPN1 provides some protection to cells against pro-apoptotic insults distinct from the OPMD mutation such as staurosporine treatment and Bax expression. Conversely, PABPN1 knockdown (which itself is not toxic) makes cells more susceptible to apoptotic stimuli. The protective effect of wild-type PABPN1 is mediated by its regulation of X-linked inhibitor of apoptosis (XIAP) protein translation. This normal activity of PABPN1 is partially lost for mutant PABPN1; elevated levels of XIAP are seen in mice expressing a wild-type but not a mutant PABPN1 transgene. This raises the possibility that a co...Continue Reading

References

Jan 7, 1998·The Journal of Cell Biology·K G WolterR J Youle
Dec 10, 1997·Neuromuscular Disorders : NMD·F M ToméM Fardeau
May 20, 1998·Pediatric Neurology·S I Pascual PascualI Pascual-Castroviejo
Nov 13, 1999·Nature Cell Biology·M HolcikR G Korneluk
Sep 5, 2002·Neuromuscular Disorders : NMD·D S Tews
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andréa C LeBlanc
Nov 20, 2003·Nature Genetics·William A IrwinPaolo Bonaldo
May 26, 2004·Biochimica Et Biophysica Acta·Uwe Kühn, Elmar Wahle
Dec 4, 2004·The Journal of Clinical Investigation·Mahasweta GirgenrathJeffrey Boone Miller
Sep 6, 2005·Human Molecular Genetics·Zdenek BergerCahir J O'Kane
Nov 25, 2005·Gene Therapy·J RenwickC Tsilfidis
Mar 15, 2006·The International Journal of Biochemistry & Cell Biology·Janet E DaviesDavid C Rubinsztein
Apr 28, 2006·The EMBO Journal·Aymeric ChartierMartine Simonelig
May 3, 2006·Trends in Molecular Medicine·Jeffrey B Miller, Mahasweta Girgenrath
Oct 4, 2006·EMBO Reports·Brendan P EckelmanFiona L Scott

❮ Previous
Next ❯

Citations

Dec 17, 2008·Current Neurology and Neuroscience Reports·Bernard Brais
Sep 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sohini ChakraborteeAlan Tunnacliffe
Dec 26, 2009·Human Molecular Genetics·Luciano H ApponiGrace K Pavlath
Jan 5, 2011·Human Molecular Genetics·Janet E Davies, David C Rubinsztein
Jun 4, 2010·Science Translational Medicine·Janet E DaviesDavid C Rubinsztein
Oct 19, 2014·The Journal of Physiology·Matthew E RandolphGrace K Pavlath
Sep 21, 2013·Drug Discovery Today. Technologies·Aymeric Chartier, Martine Simonelig
Dec 23, 2008·Journal of the Neurological Sciences·Hung-Chou KuoChin-Chang Huang
Jun 3, 2009·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Kazuya ToriumiShoichi Ishiura
Apr 23, 2013·The FEBS Journal·Ayan BanerjeeAnita H Corbett
Jul 4, 2008·American Journal of Human Genetics·Marco BaralleFranco Pagani
Nov 27, 2014·Frontiers in Aging Neuroscience·Yotam Raz, Vered Raz
Apr 1, 2017·Nature Communications·A MalerbaG Dickson
Dec 12, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Alicia Alonso-JimenezJordi Diaz-Manera
Nov 18, 2016·Journal of Neuromuscular Diseases·B M van der SluijsB G M van Engelen
Dec 17, 2016·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Marisa Cruz-AguilarJuan C Zenteno
May 9, 2019·Journal of Cachexia, Sarcopenia and Muscle·Pradeep HarishGeorge Dickson
Apr 4, 2020·The Journal of Investigative Dermatology·Shakur MohibiXinbin Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.